TW
Todd Franklin Watanabe (See Remarks) filed 4 Form 4 reports in the past 24 months (0 purchases, 4 sales), most often in Arcutis Biotherapeutics, Inc. (ARQT). The largest single filing was $272K of ARQT (20,880 sh × $13.03, as filed), executed Mar 3 2025. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
4
0 buys · 4 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$919K
shares × price, as filed
Last traded
May 2 2025
Filed May 5 2025
Median ADV $51.3M across their filed names
Open performance→Volume by month
Buys $0
Sells $919K
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
4 filings
Sector per market data · by filing · past 24 months
Most traded names
ARQTRecent filings
ARQTSALE
Arcutis Biotherapeutics, Inc.
View filing →
$174K11,448 sh × $15.19
Exec May 2 2025
Filed May 5 2025 · 5:30 PM ET ARQTSALE Arcutis Biotherapeutics, Inc. View filing → $272K
20,880 sh × $13.03
Exec Mar 3 2025
Filed Mar 4 2025 · 5:30 PM ET ARQTSALE Arcutis Biotherapeutics, Inc. View filing → $245K
19,301 sh × $12.70
Exec Feb 3 2025
Filed Feb 4 2025 · 5:30 PM ET ARQTSALE Arcutis Biotherapeutics, Inc. View filing → $228K
15,000 sh × $15.17
Exec Dec 20 2024
Filed Dec 23 2024 · 5:30 PM ET ARQTSALE Arcutis Biotherapeutics, Inc. View filing → $120K
13,871 sh × $8.68
Exec Nov 4 2024
Filed Nov 5 2024 · 5:30 PM ET